Copyright
©The Author(s) 2024.
World J Gastroenterol. Apr 28, 2024; 30(16): 2220-2232
Published online Apr 28, 2024. doi: 10.3748/wjg.v30.i16.2220
Published online Apr 28, 2024. doi: 10.3748/wjg.v30.i16.2220
Figure 7 Immune-related adverse events gastritis.
Esophagogastroduodenoscopy images after 16 wk of pembrolizumab administration in a 57-year-old female. A: White exudate and coarse mucosa are observed in the gastric body; B: Magnifying observation with narrow-band imaging shows that the glandular structures are absent.
- Citation: Iwamuro M, Kawano S, Otsuka M. Drug-induced mucosal alterations observed during esophagogastroduodenoscopy. World J Gastroenterol 2024; 30(16): 2220-2232
- URL: https://www.wjgnet.com/1007-9327/full/v30/i16/2220.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i16.2220